(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 4.19% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Thermo Fisher Scientific's revenue in 2025 is $43,736,000,000.On average, 28 Wall Street analysts forecast TMO's revenue for 2025 to be $16,808,051,435,483, with the lowest TMO revenue forecast at $16,230,588,148,800, and the highest TMO revenue forecast at $17,532,040,865,176. On average, 28 Wall Street analysts forecast TMO's revenue for 2026 to be $17,638,741,953,932, with the lowest TMO revenue forecast at $16,935,416,467,484, and the highest TMO revenue forecast at $18,514,517,439,461.
In 2027, TMO is forecast to generate $18,610,698,702,565 in revenue, with the lowest revenue forecast at $17,782,262,432,470 and the highest revenue forecast at $19,845,651,092,498.